SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-20-326184
Filing Date
2020-12-23
Accepted
2020-12-23 17:17:28
Documents
2
Group Members
VERSANT SIDE FUND IV, L.P.VERSANT VENTURE CAPITAL IV, L.P.VERSANT VENTURE MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d30259dsc13da.htm SC 13D/A 86291
2 EX-99.5 d30259dex995.htm EX-99.5 6149
  Complete submission text file 0001193125-20-326184.txt   94201
Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 650-233-2211
Versant Ventures IV, LLC (Filed by) CIK: 0001456589 (see all company filings)

IRS No.: 263080143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88266 | Film No.: 201413535
SIC: 2836 Biological Products, (No Diagnostic Substances)